| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ercros S.A (MC: ECR)
ECR Technical Analysis
5
| As on 21st Nov 2024 ECR STOCK Price closed @ 3.53 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.96 & Strong Buy for SHORT-TERM with Stoploss of 3.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ECRSTOCK Price
| Open | 3.52 | Change | Price | % |
| High | 3.54 | 1 Day | 0.01 | 0.28 |
| Low | 3.52 | 1 Week | -0.02 | -0.56 |
| Close | 3.53 | 1 Month | -0.03 | -0.84 |
| Volume | 4931 | 1 Year | 0.31 | 9.63 |
| 52 Week High 3.95 | 52 Week Low 2.28 | ||||
MC Spain Most Active Stocks
| UBS | 0.00 | % |
| SAN | 4.53 | 0.44% |
| CABK | 5.46 | 0.92% |
| DIA | 0.01 | 0.00% |
| IAG | 2.96 | 1.72% |
| TEF | 4.26 | -1.62% |
| SAB | 1.84 | 0.55% |
| IBE | 13.32 | -0.22% |
| BBVA | 9.25 | 0.22% |
| UNI | 1.24 | 0.81% |
MC Spain Top Gainers Stocks
MC Spain Top Losers Stocks
| ECR Daily Charts |
ECR Intraday Charts |
Whats New @ Bazaartrend |
ECR Free Analysis |
|
|
ECR Important Levels Intraday
| RESISTANCE | 3.57 |
| RESISTANCE | 3.56 |
| RESISTANCE | 3.55 |
| RESISTANCE | 3.54 |
| SUPPORT | 3.52 |
| SUPPORT | 3.51 |
| SUPPORT | 3.50 |
| SUPPORT | 3.49 |
ECR Forecast November 2024
| 4th UP Forecast | 4.26 |
| 3rd UP Forecast | 4.03 |
| 2nd UP Forecast | 3.88 |
| 1st UP Forecast | 3.74 |
| 1st DOWN Forecast | 3.32 |
| 2nd DOWN Forecast | 3.18 |
| 3rd DOWN Forecast | 3.03 |
| 4th DOWN Forecast | 2.8 |
ECR Weekly Forecast
| 4th UP Forecast | 4.13 |
| 3rd UP Forecast | 3.94 |
| 2nd UP Forecast | 3.82 |
| 1st UP Forecast | 3.70 |
| 1st DOWN Forecast | 3.36 |
| 2nd DOWN Forecast | 3.24 |
| 3rd DOWN Forecast | 3.12 |
| 4th DOWN Forecast | 2.93 |
ECR Forecast2024
| 4th UP Forecast | 6.84 |
| 3rd UP Forecast | 5.78 |
| 2nd UP Forecast | 5.12 |
| 1st UP Forecast | 4.47 |
| 1st DOWN Forecast | 2.59 |
| 2nd DOWN Forecast | 1.94 |
| 3rd DOWN Forecast | 1.28 |
| 4th DOWN Forecast | 0.22 |
Ercros S.A ( MC Spain Symbol : ECR )
Sector : Basic Materials And Other Stocks in Same Sector
Sector : Basic Materials And Other Stocks in Same Sector
ECR Business Profile
Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three divisions: Chlorine Derivatives, Intermediate Chemicals, and Pharmaceuticals. The Chlorine Derivatives division produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, vinyl chloride monomer and polychloride, and trichloroisocyanuric acid. Its products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; produce compound feed and in cooling equipment; and others. The Intermediate Chemicals division provides formaldehyde, glues and resins, moulding compounds, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing resins, paints, varnishes, sockets and switches, tableware, health and packaging items, particles, and decorative laminated and plywood boards, as well as for use in the textile tanning industry. The Pharmaceuticals division engages in the manufacturing of raw materials and intermediate pharmaceutical products of antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal products. Its products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, fosfomycin calcium and sodium, fosfomycin trometamol, and fusidic acid. The company also exports its products. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain. Address: Avinguda Diagonal, 593-595, Barcelona, Spain, 08014
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service